AMRN Q1 2025 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$42M-25.7% YoY

Gross Profit

$25M59.8% margin

Operating Income

-$17M-39.9% margin

Net Income

-$16M-37.4% margin

EPS (Diluted)

$-0.76

QoQ Revenue Growth

-32.6%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$656M

Total Liabilities

$182M

Stockholders' Equity

$474M

Cash & Equivalents

$120M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$57M	-25.7%
Gross Profit	$25M	$32M	-21.2%
Operating Income	-$17M	-$14M	-23.4%
Net Income	-$16M	-$10M	-57.7%

Revenue Segments

Product

$41M98%

Licensing And Royalty

$982,0002%

Geographic Segments

UNITED STATES

$36M87%

Europe

$5M13%